Back to search

National and Kapodistrian University of Athens

Διερεύνηση της οδού μεταγωγής σήματος του TGF-B σε αδενοκαρκινώματα στομάχου

Abstract

dc:description

Background: Transforming growth factor-β (TGF-β) is a cytokine with a dual role in carcinogenesis. Its tumor suppressive role is believed to be accomplished mainly through the activation of Cyclin-Dependent Kinase Inhibitors, which act as cell cycle regulators. The pro-oncogenic effect of TGF-β is believed to be mediated through extracellular matrix production and the induction of angiogenesis and immunosuppression. Among the three recognized isoforms of TGF-β, TGF-β1 is the best studied and was found to be overexpressed in human cancer tissue. TGF-β1 signal transduction includes binding of the protein to a cell surface receptor which leads to intracellular signalling initiation, in which SMAD4 plays a pivotal role. Cyclin-Dependent Kinase Inhibitor, p15 is one of the main targets of SMAD4 transcription complex, when the later one enters the nucleus. Objectives: The aim of this study was to investigate TGF-β1 pathway in human gastric carcinomas. The expression of TGF-β1, SMAD4 and p15 proteins was studied in a series of 63 gastric carcinomas, in relation with angiogenesis, clinicopathological parameters (gender, age, histologic type, histologic grade, tumor location, stage of disease) and patients survival. Materials and Methods: Specimens where obtained from 63 patients, operated for primary gastric cancer. The patients aged from 36 to 88 years (mean age 70 years). Patient’s mean survival time was19 months (range from 1 to 84 months). TGF-β1, SMAD4 and p15 expressions were investigated by means of immunohistochemistry (EnVision+ System-HRP) using monoclonal antibodies. Angiogenesis was also studied based on image analysis technique. Statistical analysis was performed using the SPSS10 statistical program. Results: TGF-β1 expression was detected in 25 (40%) of gastric carcinomas, while 30 (47.6%) cases presented preserved expression of SMAD4 and 18 cases were positive for p15 protein expression. In 7 cases, (11%) co-expression of the three proteins was observed. Expression of p15 protein was significantly associated with SMAD4 expression, (p=0.001). However, TGF-β1 expression was not found to be associated with SMAD4 (p=0.842) or p15 (p= 0.411) protein expression. Tumors with positive p15 expression were mostly seen in women (p=0.042), while p15 negative tumors were more frequently carcinomas of the intestinal type (p=0.036). Loss of p15 protein expression was associated with tumors located in the distal part of the stomach (p=0.041) and this was also the case for loss of SMAD4 protein expression (p=0.012). In the present study, microvessel density (MVD) ranged between 58-2153 vessels /mm2, with a mean of 444 vessels/mm2. MVD was strongly associated with TGF- β1 protein expression (Spearman’s test ρ=0.454, p<0.001), but not with the expression of the other two proteins (SMAD4 and p15). Survival statistical analysis at first demonstrated a trend for better survival (p=0.0645) in patients with TGF-β1 negative carcinomas. Survival analysis was repeated stratifying by stage of disease and this time a significant association between TGF-β1 expression and poor survival (p=0.0002) was demonstrated for stage IIIA patients. When survival analysis was stratified by the degree of tumor differentiation (good or moderate vs. poor), in the case of well or moderately differentiated tumors, survival was significantly better for patients with reduced SMAD4 expression (p=0.042). In conclusion, TGF-β1 expression does not seem to correlate with SMAD4 and p15 protein expression in human gastric carcinomas, suggesting a perturbation of TGF-β1 signalling pathway in this type of cancer. Moreover, the association between TGF-β1 expression and poor prognosis for stage IIIA patients, supports the pre-oncogenic role of TGF-β1 in carcinomas of the stomach. Induction of angiogenesis seems to contribute significantly to this role, as TGF-β1 expression was found to correlate strongly with microvessel density. On the other hand, the observed association between p15 and SMAD4 expression confirms their functional relation. Correlation of reduced SMAD4 expression with better patient’s survival in the case of well or moderately differentiated tumors, might suggest a, TGF-β1 independent, oncogenic effect of SMAD4 on gastric carcinogenesis.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Sakellariou, Stratigoula
  • Σακελλαρίου, Στρατηγούλα

Subjects

dc:subject × 17

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/24436

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Sakellariou, Stratigoula; Σακελλαρίου, Στρατηγούλα. Διερεύνηση της οδού μεταγωγής σήματος του TGF-B σε αδενοκαρκινώματα στομάχου. National and Kapodistrian University of Athens, 2010. http://hdl.handle.net/10442/hedi/24436